Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Timing of Zoster Vaccination After Shingles
NCT02704572Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Open-label trial of zoster vaccine, live in herpes zoster (HZ) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Varicella-zoster virus-specific interferon-gamma ELISPOT response at 6 weeks. Started Mar 2016; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02704572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704572.